ANAPTYSBIO, INC Quarterly Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest in USD from Q2 2023 to Q2 2024
-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.
-
Summary
-
Anaptysbio, Inc quarterly/annual Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest history and growth rate from Q2 2023 to Q2 2024.
- Anaptysbio, Inc Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest for the quarter ending June 30, 2024 was -$46.7M, a 17.1% decline year-over-year.
- Anaptysbio, Inc annual Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest for 2023 was -$164M, a 27.1% decline from 2022.
- Anaptysbio, Inc annual Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest for 2022 was -$129M, a 123% decline from 2021.
- Anaptysbio, Inc annual Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest for 2021 was -$57.8M, a 190% decline from 2020.
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest, Quarterly (USD)
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest, YoY Quarterly Growth (%)